3.0.0
3927
2023-03-08T19:58:48Z
2023-03-08T19:58:48Z
House
HR
2021-06-16
117
[Congressional Record Volume 167, Number 105 (Wednesday, June 16, 2021)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. CARTER of Georgia:H.R. 3927.Congress has the power to enact this legislation pursuantto the following:Article 1, Section 8 of the U.S. Constitution[Page H2892]
- hsif00
Energy and Commerce Committee
House
Standing
  - hsif14
Health Subcommittee
    - Referred to
2021-06-17T21:35:53Z
  - Referred to
2021-06-16T14:01:10Z
- hswm00
Ways and Means Committee
House
Standing
  - Referred to
2021-06-16T14:01:15Z

- MADE in America Act
117
2082
S
2021-06-16
Read twice and referred to the Committee on Finance.
  - Identical bill
CRS
- 2021-06-17
  - hsif14
Health Subcommittee
1
House committee actions
Referred to the Subcommittee on Health.
Committee
- 2021-06-16
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
IntroReferral
H11100
2
House floor actions
  - hswm00
Ways and Means Committee
- 2021-06-16
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
IntroReferral
H11100
2
House floor actions
  - hsif00
Energy and Commerce Committee
- 2021-06-16
Introduced in House
IntroReferral
Intro-H
9
Library of Congress
- 2021-06-16
Introduced in House
IntroReferral
1000
9
Library of Congress
- C001103
Rep. Carter, Earl L. "Buddy" [R-GA-1]
Earl
Carter
R
GA
L. "Buddy"
1
N
- R000597
Rep. Rice, Tom [R-SC-7]
Tom
Rice
R
SC
7
2021-06-16
True
- S001200
Rep. Soto, Darren [D-FL-9]
Darren
Soto
D
FL
9
2021-06-16
True
- C001090
Rep. Cartwright, Matt [D-PA-8]
Matt
Cartwright
D
PA
8
2021-06-16
True
- V000133
Rep. Van Drew, Jefferson [R-NJ-2]
Jefferson
Van Drew
R
NJ
2
2021-06-16
True
- W000821
Rep. Westerman, Bruce [R-AR-4]
Bruce
Westerman
R
AR
4
2021-06-16
True
- C001087
Rep. Crawford, Eric A. "Rick" [R-AR-1]
Eric
Crawford
R
AR
A. "Rick"
1
2021-06-16
True
- M001180
Rep. McKinley, David B. [R-WV-1]
David
McKinley
R
WV
B.
1
2021-06-16
True
- G000568
Rep. Griffith, H. Morgan [R-VA-9]
H.
Griffith
R
VA
Morgan
9
2021-06-16
True
- K000386
Rep. Katko, John [R-NY-24]
John
Katko
R
NY
24
2021-12-02
False
- B001306
Rep. Balderson, Troy [R-OH-12]
Troy
Balderson
R
OH
12
2021-12-02
False
- H001067
Rep. Hudson, Richard [R-NC-8]
Richard
Hudson
R
NC
8
2022-03-15
False
- J000304
Rep. Jackson, Ronny [R-TX-13]
Ronny
Jackson
R
TX
13
2022-03-15
False
- M001190
Rep. Mullin, Markwayne [R-OK-2]
Markwayne
Mullin
R
OK
2
2022-03-24
False
- D000628
Rep. Dunn, Neal P. [R-FL-2]
Neal
Dunn
R
FL
P.
2
2022-05-10
False
Health
Health
00
2021-06-16
Introduced in House
2022-07-14T16:30:44Z
Manufacturing API, Drugs, and Excipients in America Act or the MADE in America Act
This bill establishes a tax credit for taxpayers engaged in medical production activities in certain areas and contains other provisions related to pharmaceuticals.
An eligible taxpayer may claim a tax credit equal to 25% of qualified expenditures related to the production of pharmaceuticals, medical devices, or other related items in a designated qualified opportunity zone with a poverty rate higher than 30%. The bill provides for increases to this tax credit in certain situations, such as if a substantial portion of the employees reside in areas with certain poverty levels.
In addition, the Food and Drug Administration (FDA) must continue programs to facilitate the development and review of new drug or biological products that are manufactured using certain advanced manufacturing technologies. The bill imposes various requirements on these programs, including deadlines for evaluating such a technology.
Furthermore, the Department of Health and Human Services must ensure timely and effective internal coordination and alignment between FDA field investigators and the staff of the Center for Drug Evaluation and Research's Office of Compliance and Drug Shortage Program regarding reports and feedback related to facility inspections.

MADE in America Act
- Display Title

MADE in America Act
- Official Title as Introduced

To mitigate drug shortages and provide incentives for maintaining, expanding, and relocating the manufacturing of active pharmaceutical ingredients, excipients, medical diagnostic devices, pharmaceuticals, and personal protective equipment in the United States, and for other purposes.
Introduced in House
IH
- Short Title(s) as Introduced

MADE in America Act
Introduced in House
IH
- Short Title(s) as Introduced

Manufacturing API, Drugs, and Excipients in America Act
Introduced in House
IH
- Introduced in House
2021-06-16T04:00:00Z
  - https://www.govinfo.gov/content/pkg/BILLS-117hr3927ih/xml/BILLS-117hr3927ih.xml
2021-06-17
Referred to the Subcommittee on Health.
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
Congressional Research Service, Library of Congress
This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.